Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London · Delayed Price · Currency is GBP · Price in USD 451.70
+1.69 (0.38%)
At close: Oct 3, 2025
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 44.39 billion as of October 3, 2025. Its market cap has increased by 67.16% in one year.
Market Cap
44.39B
Enterprise Value
44.30B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
451.70
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 44.39B, an increase of 70,105.37%. That is a compound annual growth rate of 35.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 44.39B | 83.10% |
| Dec 31, 2024 | 24.24B | 28.56% |
| Dec 29, 2023 | 18.86B | -22.29% |
| Dec 30, 2022 | 24.27B | 62.00% |
| Dec 31, 2021 | 14.98B | 35.43% |
| Dec 31, 2020 | 11.06B | 14.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.55B |
| Haleon | 29.53B |
| Smith & Nephew | 11.64B |
| ConvaTec Group | 4.81B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |